353
Participants
Start Date
October 31, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Bevacizumab
Patients will receive 6 courses of bevacizumab in combination with carboplatin and paclitaxel. Bevacizumab will be administered at a dose of 15 mg/kg as 90 min intravenous infusion every 3 weeks (on Day 1 of each cycle).
Paclitaxel
Paclitaxel will be administered at a dose of 175 mg/m2 as 3 hour intravenous infusion on Day 1 of each 3-week course (6 courses totally)
Carboplatin
Carboplatin will be administered (AUC 6 mg/ml×min) as 15 - 30 min intravenous infusion just after paclitaxel on Day 1 of each 3-week course (6 courses totally).
"Institution of Russian Academy of Medical Sciences Russian Cancer Research Center named after N.N. Blokhin", Moscow
"State Health Institution of Moscow Moscow City Oncology Hospital #62 of Moscow Board of Health", Moscow Region
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk
Murmansk Regional Oncology Dispensary, Murmansk
"Federal State Institution Moscow Institute of Cancer Research named after P.A. Hertsen Ministry of Health of Russian Federation", Moscow
Saint Petersburg City Clinical Oncology Center, Saint Petersburg
St. Petersburg State Medical University n.a. I. P. Pavlov, Saint Petersburg
N.N.Petrov Oncology Research Center, Saint Petersburg
St. Petersburg Research and Practice Center for Secondary Care in Oncology, Saint Petersburg
"Regional State Health Institution Orlov Oncology Dispansary", Oryol
"State Healthcare Facility Kursk Regional Oncology Dispensary", Kursk
"Federal Government Budgetary Institution Rostov Institute of Cancer Research of Ministry of Health of Russian Federation", Rostov-on-Don
Oncology Dispensary 2, Sochi
"State-financed Health Institution Stavropol Region Clinical Oncology Dispansary", Stavropol
"State Health Institution Voronezh Region Clinical Oncology Dispansary", Voronezh
Volgograd District Oncology Dispensary №1, Volgograd
Volgograd Regional Oncology Dispensary №3, Volgograd
"State Health Institution Region Oncology Dispansary", Penza
"State-financed Health Institution Samara Region Clinical Oncology Dispansary", Samara
"Non-governmental Healthcare Institution Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways", Chelyabinsk
HCG Bangalore Institute of Oncology, Bangalore
M.S.Ramaiah Memorial Hospital, Bangalore
Narayana Hrudayalaya Hospitals, Bangalore
"Nizhny Novgorod Region State Budgetary Healthcare Facility Clinical Diagnostics Center", Nizhny Novgorod
Perm Region Oncology Dispensary, Perm
City Clinical Hospital №1, Novosibirsk
Brest Regional Clinical Dispensary, Brest
Grodno Regional Clinical Hospital, Grodno
Gomel Regional Clinical Oncology Dispensary, Homyel
Vitebsk Regional Clinical Oncology Dispensary, Vitebsk
"State-financed Health Institution Chelyabinsk Region Clinical Oncology Dispansary", Chelyabinsk
"State Healthcare Facility Nizhny Novgorod Regional Oncology Dispensary", Nizhny Novgorod
Military Medical Academy named after S.M. Kirov, Saint Petersburg
Russian scientific center of radiology and surgery technologies, Saint Petersburg
Donetsk City Oncology Dispensary, Donetsk
Donetsk Regional Antitumor Center, Donetsk
Kharkiv Regional Clinical Oncology Center, Kharkiv
Kryvyi Rih Oncology Dispensary, Kryvyi Rih
Lviv State Regional Cancer Diagnostic and Treatment Center, Lviv
City Hospital № 2, Makiivka
Poltava Regional Clinical Oncology Dispensary, Poltava
Zakarpatskyi Clinical Oncology Dispensary, Uzhhorod
Vinnytsia Regional Clinical Oncology Dispensary, Vinnytsia
Zaporizhia Regional Clinical Oncology Dispensary, Zaporizhia
Lead Sponsor
Biocad
INDUSTRY